SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-009472
Filing Date
2004-11-05
Accepted
2004-11-05 14:28:07
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD ENDED SEPTEMBER 30, 2004 a02981e10vq.htm 10-Q 151148
2 EXHIBIT 10.31 a02981exv10w31.txt EX-10.31 5833
3 EXHIBIT 10.60 a02981exv10w60.txt EX-10.60 10239
4 EXHIBIT 31.1 a02981exv31w1.txt EX-31.1 3821
5 EXHIBIT 31.2 a02981exv31w2.txt EX-31.2 3874
6 EXHIBIT 32.1 a02981exv32w1.txt EX-32.1 1981
  Complete submission text file 0000950137-04-009472.txt   179041
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 041122309
SIC: 2836 Biological Products, (No Diagnostic Substances)